Cargando…
Targeted metabolomic analysis of nitric oxide/L-arginine pathway metabolites in dementia: association with pathology, severity, and structural brain changes
L-Arginine/NO pathway is altered in Alzheimer disease (AD). Its clinical relevance and pathway status in vascular dementia (VaD) are unknown. Using targeted metabolomics (a liquid chromatography-mass spectrometry) we assessed L-arginine, L-citrulline, dimethylamine (DMA), asymmetric dimethyl arginin...
Autores principales: | Fleszar, Mariusz G., Wiśniewski, Jerzy, Zboch, Marzena, Diakowska, Dorota, Gamian, Andrzej, Krzystek-Korpacka, Małgorzata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760237/ https://www.ncbi.nlm.nih.gov/pubmed/31551443 http://dx.doi.org/10.1038/s41598-019-50205-0 |
Ejemplares similares
-
Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS)
por: Krzystek-Korpacka, Małgorzata, et al.
Publicado: (2019) -
Quantitative Analysis of l-Arginine, Dimethylated Arginine Derivatives, l-Citrulline, and Dimethylamine in Human Serum Using Liquid Chromatography–Mass Spectrometric Method
por: Fleszar, Mariusz G., et al.
Publicado: (2018) -
Esophageal Squamous Cell Carcinoma Is Accompanied by Local and Systemic Changes in L-arginine/NO Pathway
por: Bednarz-Misa, Iwona, et al.
Publicado: (2020) -
Altered L-Arginine Metabolic Pathways in Gastric Cancer: Potential Therapeutic Targets and Biomarkers
por: Bednarz-Misa, Iwona, et al.
Publicado: (2021) -
Tumor location determines midkine level and its association with the disease progression in colorectal cancer patients: a pilot study
por: Krzystek-Korpacka, Malgorzata, et al.
Publicado: (2012)